What is INDOSE?
INDOSE is pioneering the world's first real-time, metered precise dosage vaporizer. Co-founded by Benzi Ronen, former CEO of Farmigo, and brothers Ari and Dani Freeman, the company leverages extensive product launch experience, having introduced numerous products to thousands of retailers globally and previously raising over $100 MM in financing. Their innovative approach targets a precise and controlled user experience in the vaporizer market.
How much funding has INDOSE raised?
INDOSE has raised a total of $3.6M across 2 funding rounds:
Series A
$3.5M
Debt
$145K
Series A (2019): $3.5M with participation from Casa Verde Capital
Debt (2021): $145K led by PPP
Key Investors in INDOSE
Casa Verde Capital
Casa Verde Capital is a leading venture capital firm exclusively focused on the cannabis industry, investing in scalable businesses led by world-class management teams.
PPP
Public-Private Partnership
What's next for INDOSE?
The recent major strategic investment signals a pivotal growth phase for INDOSE. This capital is expected to fuel further product development, market expansion, and potentially enhance manufacturing capabilities. The company's focus on precise dosage vaporization positions it to capture a significant share of a growing market, with strategic backing likely aimed at scaling operations and solidifying its market leadership.
See full INDOSE company page
